INS and sarcopenia: Skeletal muscle accounts for approximately 80% of insulin‐mediated glucose uptake, and thus the loss of skeletal muscle mass and function related to sarcopenia is the primary defect that directly prompts impaired muscle glycogen synthesis and insulin resistance (DeFronzo & Tripathy, 2009).